FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2059100544> ?p ?o ?g. }

• W2059100544 endingPage "16" @default.
• W2059100544 startingPage "7" @default.
• W2059100544 abstract "Objective. To provide a comprehensive overview of the various endocrine therapies being developed and investigated for the treatment of symptomatic benign prostatic hyperplasia (BPH). Methods. Peer-reviewed reports in the medical and urologic literature were examined for pertinent information relating to the role of luteinizing hormone-releasing hormone (LHRH) agonists, antiandrogens, 5a-reductase inhibitors, and aromatase inhibitors in the management of BPH. Special attention was given to the scientific rationale and clinical results for each therapy. Results. LHRH agonists, antiandrogens, and 5a-reductase inhibitors all reduce the androgenic stimulation to the prostate gland. In doing so, they decrease prostate size by 25 percent, but cause a modest improvement in symptom score (3–4 points) and peak urinary flow rate (approximately 2.5 mUsec). All of these therapies cause a significant decrease in the serum prostate-specific antigen (PSA) concentration, and an effect is maintained as long as the treatment is continued. Side effects are most pronounced for the LHRH agonists, in which impotency and decreased libido are universal phenomena, and least significant for the 5a-reductase inhibitors. Aromatase inhibitors eliminate the estrogenic stimulation to the prostate gland. Although substantial evidence exists to support the role of estrogens in the development and maintenance of BPH, no data from large-scale randomized clinical trials are available to document the clinical usefulness of aromatase inhibitors in the treatment of symptomatic BPH. Conclusions. Medications that produce a state of androgen deprivation can reduce the static component of BPH. Of these agents, the 5α-reductase inhibitors have the greatest promise because of their low toxicity profile. The role of the aromatase inhibitors in the treatment of BPH remains to be determined." @default.
• W2059100544 created "2016-06-24" @default.
• W2059100544 creator A5041961633 @default.
• W2059100544 date "1994-02-01" @default.
• W2059100544 modified "2023-09-26" @default.
• W2059100544 title "Endocrine therapies for symptomatic benign prostatic hyperplasia" @default.
• W2059100544 cites W107210901 @default.
• W2059100544 cites W1247179837 @default.
• W2059100544 cites W14779780 @default.
• W2059100544 cites W1966408814 @default.
• W2059100544 cites W1976587221 @default.
• W2059100544 cites W1980245302 @default.
• W2059100544 cites W1981050682 @default.
• W2059100544 cites W1982815487 @default.
• W2059100544 cites W1988960647 @default.
• W2059100544 cites W1992103956 @default.
• W2059100544 cites W1999907152 @default.
• W2059100544 cites W1999962914 @default.
• W2059100544 cites W2003648033 @default.
• W2059100544 cites W2008481614 @default.
• W2059100544 cites W2009327670 @default.
• W2059100544 cites W2010245636 @default.
• W2059100544 cites W2037898758 @default.
• W2059100544 cites W2043557227 @default.
• W2059100544 cites W2047957623 @default.
• W2059100544 cites W2048201041 @default.
• W2059100544 cites W2076739340 @default.
• W2059100544 cites W2077118870 @default.
• W2059100544 cites W2077889556 @default.
• W2059100544 cites W2083847218 @default.
• W2059100544 cites W2092790183 @default.
• W2059100544 cites W2101325314 @default.
• W2059100544 cites W2132135021 @default.
• W2059100544 cites W2148922824 @default.
• W2059100544 cites W2159154550 @default.
• W2059100544 cites W2317511325 @default.
• W2059100544 cites W2318158772 @default.
• W2059100544 cites W2395726816 @default.
• W2059100544 cites W2398489306 @default.
• W2059100544 cites W2399033839 @default.
• W2059100544 cites W2402269273 @default.
• W2059100544 cites W2404145601 @default.
• W2059100544 cites W2405109010 @default.
• W2059100544 cites W2408116045 @default.
• W2059100544 cites W2411922780 @default.
• W2059100544 cites W2413807957 @default.
• W2059100544 cites W2728830059 @default.
• W2059100544 cites W3047376559 @default.
• W2059100544 cites W4231796662 @default.
• W2059100544 cites W4243205975 @default.
• W2059100544 cites W4251469393 @default.
• W2059100544 cites W7388466 @default.
• W2059100544 doi "https://doi.org/10.1016/0090-4295(94)90212-7" @default.
• W2059100544 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7509536" @default.
• W2059100544 hasPublicationYear "1994" @default.
• W2059100544 type Work @default.
• W2059100544 sameAs 2059100544 @default.
• W2059100544 citedByCount "16" @default.
• W2059100544 countsByYear W20591005442013 @default.
• W2059100544 countsByYear W20591005442015 @default.
• W2059100544 countsByYear W20591005442016 @default.
• W2059100544 crossrefType "journal-article" @default.
• W2059100544 hasAuthorship W2059100544A5041961633 @default.
• W2059100544 hasConcept C121608353 @default.
• W2059100544 hasConcept C126322002 @default.
• W2059100544 hasConcept C126894567 @default.
• W2059100544 hasConcept C134018914 @default.
• W2059100544 hasConcept C2775874879 @default.
• W2059100544 hasConcept C2776166826 @default.
• W2059100544 hasConcept C2776235491 @default.
• W2059100544 hasConcept C2777562237 @default.
• W2059100544 hasConcept C2777911890 @default.
• W2059100544 hasConcept C2779322244 @default.
• W2059100544 hasConcept C2910016293 @default.
• W2059100544 hasConcept C29456083 @default.
• W2059100544 hasConcept C46699223 @default.
• W2059100544 hasConcept C530470458 @default.
• W2059100544 hasConcept C71315377 @default.
• W2059100544 hasConcept C71924100 @default.
• W2059100544 hasConceptScore W2059100544C121608353 @default.
• W2059100544 hasConceptScore W2059100544C126322002 @default.
• W2059100544 hasConceptScore W2059100544C126894567 @default.
• W2059100544 hasConceptScore W2059100544C134018914 @default.
• W2059100544 hasConceptScore W2059100544C2775874879 @default.
• W2059100544 hasConceptScore W2059100544C2776166826 @default.
• W2059100544 hasConceptScore W2059100544C2776235491 @default.
• W2059100544 hasConceptScore W2059100544C2777562237 @default.
• W2059100544 hasConceptScore W2059100544C2777911890 @default.
• W2059100544 hasConceptScore W2059100544C2779322244 @default.
• W2059100544 hasConceptScore W2059100544C2910016293 @default.
• W2059100544 hasConceptScore W2059100544C29456083 @default.
• W2059100544 hasConceptScore W2059100544C46699223 @default.
• W2059100544 hasConceptScore W2059100544C530470458 @default.
• W2059100544 hasConceptScore W2059100544C71315377 @default.
• W2059100544 hasConceptScore W2059100544C71924100 @default.
• W2059100544 hasLocation W20591005441 @default.
• W2059100544 hasLocation W20591005442 @default.
• W2059100544 hasOpenAccess W2059100544 @default.

• next